https://www.selleckchem.com/pr....oducts/sch-900776.ht
The primary outcome will depressive symptoms improvement as assessed by the Montgomery-Asberg Depression Rating Scale (MADRS) at 6-weeks. The secondary aim is to test whether CBT combined with tDCS can engage the proposed mechanistic target of restoring the prefrontal imbalance and connectivity through the bilateral modulation of the DLPFC, as assessed by changes over resting-state and emotional task eliciting EEG. Discussion This study evaluates the synergetic clinical effects of CBT and tDCS in the first episode, drug-naïve, patien
Like
Comment
Share
